Key Takeaways
- Asian race, male sex, younger age, and lower neighborhood deprivation were associated with higher odds of low-dose atropine treatment.
- • Low-dose atropine treatment was associated with slower myopia progression.
Demographic, socioeconomic, and clinical factors were associated with both the likelihood of receiving low-dose atropine and the rate of myopia progression amongst pediatric patients in a retrospective analysis.
The data presented at AAO 2026, found that Asian race, male sex, younger age, and lower neighborhood deprivation were associated with greater odds of treatment, and treatment was associated with slower myopia progression.
Among 3,308 patients aged 3 to 17 who received low-dose atropine between January 2017 and June 2023, Asian race, male sex, younger age, and lower neighborhood deprivation index were associated with higher adjusted odds of treatment (all P < 0.001). Astigmatism and amblyopia were associated with lower odds of treatment (adjusted odds ratio, 0.74 and 0.63, respectively; both P < 0.01).
Slower myopia progression was associated with low-dose atropine treatment (0.07 D/year; P < 0.01), increasing age (0.05 D/year; P < 0.01), male sex (0.05 D/year; P = 0.006), and amblyopia (0.08 D/year; P = 0.019).
Reference
Muminovic I, et al. Effectiveness and Implementation of a Myopia Control Program in an Integrated Health-Care System in Northern California. Presented at: American Academy of Ophthalmology 2026 Annual Meeting; October 9-12, 2026; New Orleans, LA.
Related Content
